Rapid Pathogen Screening Inc - Company Review
Rapid Pathogen Screening Inc - Company ReviewSummary
Rapid Pathogen Screening Inc (Rapid Pathogen) is a biotechnology company that designs, develops, manufactures and markets point-of-care diagnostic tests. The company uses its patented direct sampling micro-filtration and direct multi-planar chromafiltography technology to develop various tests. Its product portfolio includes AdenoPlus, a CLIA-waived, point-of-care test that identifies serotypes of adenoviral conjunctivitis; and the InflammaDry test for dry eye. Rapid Pathogen’s FebriDx test helps to identify pathogen induced immune response to viral and bacterial acute febrile respiratory infection. The company develops solutions for infectious diseases and inflammatory conditions. It also offers bio-terrorism and chemical nerve agent blood toxin solutions. Rapid Pathogen is headquartered in Sarasota, Florida, the US.
This comprehensive company report of Rapid Pathogen Screening Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.